Lapatinib NEW

Description:

Lapatinib is a medication used in the treatment of certain types of breast cancer and other cancers. 

It belongs to a class of drugs known as tyrosine kinase inhibitors, which work by blocking specific proteins that are involved in the growth and spread of cancer cells.

Lapatinib is typically prescribed for patients with HER2-positive breast cancer, which is a type of breast cancer that overexpresses the human epidermal growth factor receptor 2 (HER2) protein. 

By targeting HER2, lapatinib helps to inhibit the growth of cancer cells and may slow down the progression of the disease.

In addition to breast cancer, lapatinib may also be used in combination with other medications to treat other types of cancer, such as certain types of lung cancer and head and neck cancer.

Lapatinib is taken orally in the form of tablets. The dosage and treatment regimen will be determined by a healthcare provider based on the type and stage of cancer, as well as the individual's overall health and response to treatment.

Common side effects of lapatinib may include diarrhea, nausea, rash, fatigue, and liver toxicity. 

It is important to report any severe or persistent side effects to a healthcare provider.

Overall, lapatinib is an important medication in the treatment of certain types of cancer, particularly HER2-positive breast cancer. 

It is essential to work closely with a healthcare provider to determine if lapatinib is the right treatment option and to monitor for any potential side effects or complications associated with its use.

Payment method: T/T in advance, Paypal, Western Union, L/C, etc.

Shipping ways: Courier, Air, Sea, Road

Storage Condition: Dry, dark, and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).